Related Experiment Video
Updated: Jun 10, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD
Vincent L Chen1, Timothy R Morgan2,3, Yaron Rotman4
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
No abstract available in PubMed .
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Myocarditis IV: Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Atherosclerosis III: Management
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Mitral Regurgitation IV: Nursing Management
Nephrotic Syndrome III : Nursing Management